Cargando…
Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation
BACKGROUND: To understand our performance with respect to the collection and reporting of patient-reported outcome (PRO) measure (PROM) data, we examined the protocol content, data completeness and publication of PROs from interventional trials conducted at the Royal Marsden NHS Foundation Trust (RM...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780410/ https://www.ncbi.nlm.nih.gov/pubmed/36547735 http://dx.doi.org/10.1186/s41687-022-00529-9 |
_version_ | 1784856831630245888 |
---|---|
author | Lidington, Emma Hogan, Holly Gandolfi, Ann Lawrence, Jane Younger, Eugenie Cho, Helena Peckitt, Clare Mohammed, Kabir Matharu, Sheila Scerri, Lisa Husson, Olga Cruickshank, Susanne Turner, Rachel Wedlake, Linda |
author_facet | Lidington, Emma Hogan, Holly Gandolfi, Ann Lawrence, Jane Younger, Eugenie Cho, Helena Peckitt, Clare Mohammed, Kabir Matharu, Sheila Scerri, Lisa Husson, Olga Cruickshank, Susanne Turner, Rachel Wedlake, Linda |
author_sort | Lidington, Emma |
collection | PubMed |
description | BACKGROUND: To understand our performance with respect to the collection and reporting of patient-reported outcome (PRO) measure (PROM) data, we examined the protocol content, data completeness and publication of PROs from interventional trials conducted at the Royal Marsden NHS Foundation Trust (RM) and explored factors associated with data missingness and PRO publication. DESIGN: From local records, we identified closed, intervention trials sponsored by RM that opened after 1995 and collected PROMs as primary, secondary or exploratory outcomes. Protocol data were extracted by two researchers and scored against the SPIRIT-PRO (PRO protocol content checklist; score 0–100, higher scores indicate better completeness). For studies with locally held datasets, the information team summarized for each study, PRO completion defined as the number of expected (as per protocol) PRO measurements versus the number of actual (i.e. completed) PRO measurements captured in the study data set. Relevant publications were identified by searching three online databases and chief investigator request. Data were extracted and each publication scored against the CONSORT-PRO (PRO manuscript content checklist; scored as SPIRIT-PRO above). Descriptive statistics are presented with exploratory comparisons of point estimates and 95% confidence intervals. RESULTS: Twenty-six of 65 studies were included in the review. Nineteen studies had accessible datasets and 18 studies published at least one article. Fourteen studies published PRO results. Most studies had a clinical (rather than PRO) primary outcome (16/26). Across all studies, responses in respect of 35 of 69 PROMs were published. Trial protocols scored on average 46.7 (range 7.1–92.9) on the SPIRIT-PRO. Among studies with accessible data, half (10/19) had less than 25% missing measurements. Publications scored on average 80.9 (range 36–100%) on the CONSORT-PRO. Studies that published PRO results had somewhat fewer missing measurements (19% [7–32%] vs 60% [− 26 to 146%]). For individual PROMs within studies, missing measurements were lower for those that were published (17% [10–24%] vs 41% [18–63%]). Studies with higher SPIRIT-PRO scores and PROs as primary endpoints (13% [4–22%] vs 39% [10–58%]) had fewer missing measurements. CONCLUSIONS: Missing data may affect publication of PROs. Extent of inclusion of SPIRIT-PRO protocol items and PROs as primary endpoints may improve data completeness. Preliminary evidence from the study suggests a future larger study examining the relationship between PRO completion and publication is warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-022-00529-9. |
format | Online Article Text |
id | pubmed-9780410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-97804102022-12-24 Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation Lidington, Emma Hogan, Holly Gandolfi, Ann Lawrence, Jane Younger, Eugenie Cho, Helena Peckitt, Clare Mohammed, Kabir Matharu, Sheila Scerri, Lisa Husson, Olga Cruickshank, Susanne Turner, Rachel Wedlake, Linda J Patient Rep Outcomes Research BACKGROUND: To understand our performance with respect to the collection and reporting of patient-reported outcome (PRO) measure (PROM) data, we examined the protocol content, data completeness and publication of PROs from interventional trials conducted at the Royal Marsden NHS Foundation Trust (RM) and explored factors associated with data missingness and PRO publication. DESIGN: From local records, we identified closed, intervention trials sponsored by RM that opened after 1995 and collected PROMs as primary, secondary or exploratory outcomes. Protocol data were extracted by two researchers and scored against the SPIRIT-PRO (PRO protocol content checklist; score 0–100, higher scores indicate better completeness). For studies with locally held datasets, the information team summarized for each study, PRO completion defined as the number of expected (as per protocol) PRO measurements versus the number of actual (i.e. completed) PRO measurements captured in the study data set. Relevant publications were identified by searching three online databases and chief investigator request. Data were extracted and each publication scored against the CONSORT-PRO (PRO manuscript content checklist; scored as SPIRIT-PRO above). Descriptive statistics are presented with exploratory comparisons of point estimates and 95% confidence intervals. RESULTS: Twenty-six of 65 studies were included in the review. Nineteen studies had accessible datasets and 18 studies published at least one article. Fourteen studies published PRO results. Most studies had a clinical (rather than PRO) primary outcome (16/26). Across all studies, responses in respect of 35 of 69 PROMs were published. Trial protocols scored on average 46.7 (range 7.1–92.9) on the SPIRIT-PRO. Among studies with accessible data, half (10/19) had less than 25% missing measurements. Publications scored on average 80.9 (range 36–100%) on the CONSORT-PRO. Studies that published PRO results had somewhat fewer missing measurements (19% [7–32%] vs 60% [− 26 to 146%]). For individual PROMs within studies, missing measurements were lower for those that were published (17% [10–24%] vs 41% [18–63%]). Studies with higher SPIRIT-PRO scores and PROs as primary endpoints (13% [4–22%] vs 39% [10–58%]) had fewer missing measurements. CONCLUSIONS: Missing data may affect publication of PROs. Extent of inclusion of SPIRIT-PRO protocol items and PROs as primary endpoints may improve data completeness. Preliminary evidence from the study suggests a future larger study examining the relationship between PRO completion and publication is warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-022-00529-9. Springer International Publishing 2022-12-22 /pmc/articles/PMC9780410/ /pubmed/36547735 http://dx.doi.org/10.1186/s41687-022-00529-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Lidington, Emma Hogan, Holly Gandolfi, Ann Lawrence, Jane Younger, Eugenie Cho, Helena Peckitt, Clare Mohammed, Kabir Matharu, Sheila Scerri, Lisa Husson, Olga Cruickshank, Susanne Turner, Rachel Wedlake, Linda Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation |
title | Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation |
title_full | Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation |
title_fullStr | Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation |
title_full_unstemmed | Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation |
title_short | Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation |
title_sort | assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780410/ https://www.ncbi.nlm.nih.gov/pubmed/36547735 http://dx.doi.org/10.1186/s41687-022-00529-9 |
work_keys_str_mv | AT lidingtonemma assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT hoganholly assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT gandolfiann assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT lawrencejane assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT youngereugenie assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT chohelena assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT peckittclare assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT mohammedkabir assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT matharusheila assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT scerrilisa assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT hussonolga assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT cruickshanksusanne assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT turnerrachel assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation AT wedlakelinda assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation |